Lessons for fragment library design: analysis of output from multiple screening campaigns

被引:84
作者
Chen, I-Jen [1 ]
Hubbard, Roderick E. [1 ,2 ,3 ]
机构
[1] Vernalis R&D Ltd, Cambridge CB21 6GB, England
[2] Univ York, YSBL, York YO10 5YW, N Yorkshire, England
[3] Univ York, HYMS, York YO10 5YW, N Yorkshire, England
关键词
Fragment screening; Fragment based drug discovery; Library design; Chemical space; MOLECULE-BINDING-SITES; PROTEIN-LIGAND COMPLEXES; DRUG DISCOVERY; AUTOMATIC IDENTIFICATION; KINASE INHIBITORS; NMR-SPECTROSCOPY; PDBBIND DATABASE; LEAD GENERATION; AFFINITY; DRUGGABILITY;
D O I
10.1007/s10822-009-9280-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Over the past 8 years, we have developed, refined and applied a fragment based discovery approach to a range of protein targets. Here we report computational analyses of various aspects of our fragment library and the results obtained for fragment screening. We reinforce the finding of others that the experimentally observed hit rate for screening fragments can be related to a computationally defined druggability index for the target. In general, the physicochemical properties of the fragment hits display the same profile as the library, as is expected for a truly diverse library which probes the relevant chemical space. An analysis of the fragment hits against various protein classes has shown that the physicochemical properties of the fragments are complementary to the properties of the target binding site. The effectiveness of some fragments appears to be achieved by an appropriate mix of pharmacophore features and enhanced aromaticity, with hydrophobic interactions playing an important role. The analysis emphasizes that it is possible to identify small fragments that are specific for different binding sites. To conclude, we discuss how the results could inform further development and improvement of our fragment library.
引用
收藏
页码:603 / 620
页数:18
相关论文
共 87 条
[1]   An integrated approach to fragment-based lead generation: Philosophy, strategy and case studies from AstraZeneca's drug discovery programmes [J].
Albert, Jeffrey S. ;
Blomberg, Niklas ;
Breeze, Alexander L. ;
Brown, Alastair J. H. ;
Burrows, Jeremy N. ;
Edwards, Philip D. ;
Folmer, Rutger H. A. ;
Geschwindner, Stefan ;
Griffen, Ed J. ;
Kenny, Peter W. ;
Nowak, Thorsten ;
Olsson, Lise-Lotte ;
Sanganee, Hitesh ;
Shapiro, Adam B. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (16) :1600-1629
[2]  
An Jianghong, 2004, Genome Inform, V15, P31
[3]   New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine [J].
Angehrn, P ;
Buchmann, S ;
Funk, C ;
Goetschi, E ;
Gmuender, H ;
Hebeisen, P ;
Kostrewa, D ;
Link, H ;
Luebbers, T ;
Masciadri, R ;
Nielsen, J ;
Reindl, P ;
Ricklin, F ;
Schmitt-Hoffmann, A ;
Theil, FP .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (06) :1487-1513
[4]  
[Anonymous], MOE MOL OP ENV VERS
[5]   Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors [J].
Antonysamy, Stephen S. ;
Aubol, Brandon ;
Blaney, Jeff ;
Browner, Michelle F. ;
Giannetti, Anthony M. ;
Harris, Seth F. ;
Hebert, Normand ;
Hendle, Joerg ;
Hopkins, Stephanie ;
Jefferson, Elizabeth ;
Kissinger, Charles ;
Leveque, Vincent ;
Marciano, David ;
McGee, Ethel ;
Najera, Isabel ;
Nolan, Brian ;
Tomimoto, Masaki ;
Torres, Eduardo ;
Wright, Tobi .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) :2990-2995
[6]   Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets [J].
Baurin, N ;
Aboul-Ela, F ;
Barril, X ;
Davis, B ;
Drysdale, M ;
Dymock, B ;
Finch, H ;
Fromont, C ;
Richardson, C ;
Simmonite, H ;
Hubbard, RE .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (06) :2157-2166
[7]   Structural analysis of the mitotic regulator hPin1 in solution -: Insights into domain architecture and substrate binding [J].
Bayer, E ;
Goettsch, S ;
Mueller, JW ;
Griewel, B ;
Guiberman, E ;
Mayr, LM ;
Bayer, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (28) :26183-26193
[8]   The properties of known drugs .1. Molecular frameworks [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) :2887-2893
[9]   Properties of known drugs. 2. Side chains [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (25) :5095-5099
[10]   AffinDB: a freely accessible database of affinities for protein-ligand complexes from the PDB [J].
Block, Peter ;
Sotriffer, Christoph A. ;
Dramburg, Ingo ;
Klebe, Gerhard .
NUCLEIC ACIDS RESEARCH, 2006, 34 :D522-D526